Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well alisertib works in treating patients with sarcoma that
has spread to other places in the body and usually cannot be cured or controlled with
treatment (advanced) or has spread to other places in the body (metastatic). Alisertib may
stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.